This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analysts Estimate Core Laboratories (CLB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 23rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
RNGR or CLB: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RNGR vs. CLB: Which Stock Is the Better Value Option?
New Strong Sell Stocks for January 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Dim Near-Term Outlook for Oilfield Services Industry
by Zacks Equity Research
While the oilfield services industry is likely to rise from the ashes in the coming years, it should presently focus on adapting to the current market scenario.
Oil Dips to 1-Year Low on Black Friday, Energy Stocks Suffer
by Zacks Equity Research
WTI crude prices tumbled 7.7% to $50.42 per barrel on Nov 23, marking the lowest settlement since October 2017.
Core Laboratories (CLB) Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
Core Laboratories' (CLB) third-quarter results are strongly favored by the Production Enhancement segment's notable performance.
Core Laboratories (CLB) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 1.59% and 2.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Why Is Core Laboratories (CLB) Up 2.6% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q2 Earnings In Line, Revenues Up Y/Y
by Zacks Equity Research
Core Laboratories' (CLB) second-quarter results are strongly favored by the Product Enhancement segment's notable performance.
Zacks Industry Outlook Highlights: Core Laboratories, C&J Energy Services, SEACOR Holdings and Mammoth Energy Services
by Zacks Equity Research
Zacks Industry Outlook Highlights: Core Laboratories, C&J Energy Services, SEACOR Holdings and Mammoth Energy Services
New Strong Sell Stocks for July 18th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
The Zacks Analyst Blog Highlights: Enbridge, Chevron, Core Laboratories N.V. and National Oilwell Varco
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Enbridge, Chevron, Core Laboratories N.V. and National Oilwell Varco
Oil & Gas Stock Roundup: Enbridge's Midstream Sale, Chevron's North Sea Plans & More
by Nilanjan Choudhury
Enbridge (ENB) is getting rid of assets in order to pare debt, while Chevron (CVX) is set to put a number of its oil and gas fields in Britain's North Sea for sale.
Company News For Jul 3, 2018
by Zacks Equity Research
Companies in the news are: CLB, ALKS, ACXM and URI
Core Labs (CLB) Slashes Q2 Guidance, Shares Plunge 13.6%
by Zacks Equity Research
Core Laboratories (CLB) expects total revenues in the band of $174-$175 million against the prior guided range of $177-$179 million.
Why Is Core Laboratories (CLB) Up 5.3% Since Its Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TechnipFMC (FTI) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
TechnipFMC's (FTI) total backlog stands at $14,012 million compared with $16,056.2 million a year ago, reflecting a decline of 12.7%.
TechnipFMC (FTI) to Report Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
TechnipFMC (FTI) is likely to deliver an earnings beat in the first quarter on cost containment initiatives along with strong project execution.
Core Laboratories (CLB) Q1 Earnings Meet Estimates, Up Y/Y
by Zacks Equity Research
Robust performance by Production Enhancement segment leads to higher year-over-year earnings and revenues for Core Laboratories (CLB).
Core Laboratories (CLB) Q4 Earnings & Revenues Meet Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivers improved year-over-year Q4 results on the back of solid performance from its Production Enhancement.
Why Is Core Laboratories (CLB) Up 15.1% Since the Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Laboratories (CLB) Q3 Earnings & Revenues Top Estimates
by Zacks Equity Research
Despite being hit by hurricanes, Core Laboratories (CLB) reported better-than-expected third-quarter 2017 results. The results also improved year over year.